459 Followers on Owler
REGENXBIO is a Maryland-based biotechnology company that researches and develops gene therapeutics for the treatment of retinal, metabolic, and neurodegenerative diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
REGENXBIO is a Maryland-based biotechnology company that researches and develops gene therapeutics for the treatment of retinal, metabolic, and neurodegenerative diseases... Read more
Regenxbio President & CEO: Curran Simpson

President & CEO

Curran Simpson

CEO Approval Rating

83/100

2008

PublicNASDAQRGNX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$83.3M
Employees
370
Funding
$244.5M
Acquisitions
1

News

Partnership
Mar 04, 2025
Marketscreener
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
Leadership Change
Jul 02, 2024
prnewswire
Curran Simpson is now President & CEO at REGENXBIO

Regenxbio Competitors

14DMT
2Adverum
3Amicus
4BioMarin
5Homology
6MeiraGTx
7Novartis
8Passage Bio
9PTC
10Roche
Unlock 9 + competitors

Trending Companies